Further, we designed in vitro coculture assays using lung cancer cell lines and Tregs from patients’ PBs to verify that cancer cells can induce Tregs GARP expression, which may confer and launch the Treg immunosuppression at the early stage of cancer. Here, LRRC32 is linked to lung carcinoma.